AI-powered radiation reduction solution gains FDA clearance

Sanford, Florida-based Omega Medical Imaging announced that its new FluoroShield radiation reduction system has received FDA approval.

The AI-powered imaging solution reduces patients’ exposure to radiation and produces high-quality blended images to be used during interventional procedures. It can also be positioned manually, giving users more freedom than normal as they care for patients.

According to Omega Medical Imaging, this is the first solution of its kind to hit the market.

“FluoroShield is the only system in the world that provides an actual reduction in dose,” Brian Fleming, president of Omega Medical Imaging, said in a prepared statement. “The impact of this groundbreaking solution for patients and healthcare providers is substantial. I am very grateful to be a part of a team that pushes the envelope in the development of safer healthcare solutions.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.